sepsis Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance The quality controls are designed to verify the performance of the Luminex Verigene Blood Culture Gram-Positive and Gram-Negative tests. T2 Biosystems, Vanderbilt University Medical Center Partner on Prospective Bacterial Sepsis Dx Study The medical center will evaluate whether the T2Bacteria Panel improves antibiotic usage and clinical interventions for sepsis patients. Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike Premium Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies. Todos Medical Subsidiary Inks US Commercialization Deal for Acumen Diagnostics Sepsis PCR Test Todos Medical acquired the subsidiary, Provista Diagnostics, in early 2021 from Ascenda Biosciences for $7.5 million in cash and stock. Immunexpress Begins US Commercialization of Near-Patient Sepsis Diagnostic Test Premium The company's test uses qPCR to measure the expression of two genes to determine the probability of sepsis. Jan 17, 2023 Blu Biotech Sniffing Out Infections, Cancer With Multi-Disease Breathalyzer Premium Jan 3, 2023 Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022 Premium Dec 13, 2022 DeepUll Inks €20M Loan Agreement With European Investment Bank Nov 7, 2022 Cepheid Nabs CE Mark for Group B Strep Test Nov 7, 2022 Oxford, Sanger Institute Researchers Draw on Gene Expression Testing for Sepsis Risk Algorithm Premium Oct 28, 2022 DeepUll Developing Multiplex PCR System to Serve as Future Frontline Sepsis Test Premium Oct 20, 2022 Sepsis Testing Startup DeepUll Raises €13M Oct 20, 2022 Day Zero Diagnostics Secures Additional $8.2M From CARB-X Aug 10, 2022 VolitionRx, MD Anderson Cancer Center Partner to Study Cancer Patients With Sepsis Jul 6, 2022 T2 Biosystems Reports Preliminary Drop in Q2 Revenues, Cuts Workforce May 24, 2022 BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel Apr 1, 2022 T2 Biosystems Exercises BARDA Contract Option Valued at $4.4M Apr 1, 2022 UK Startup Great North Research & Innovation Awarded $319K to Develop Point-of-Care Sepsis Diagnostic Premium Jan 28, 2022 Streck Gets FDA Clearance for BioFire Sepsis Panel Control Material Nov 30, 2021 Immunexpress Receives FDA 510(k) Clearance for Sepsis Assay Nov 4, 2021 T2 Biosystems Q3 Revenues Jump 42 Percent Oct 4, 2021 BARDA Exercises $6.4M Option on T2 Biosystems Contract Sep 9, 2021 UK Startup Presymptom Health Developing Host-Response Prognostic Test for Sepsis Premium Aug 5, 2021 T2 Biosystems Q2 Revenues More Than Double, Beat Estimates May 20, 2021 With Finder Platform, Baebies Works to Expand Options for Neonatal Dx Testing Premium Load More Breaking News NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore FDA Approves Entrogen's RAS Mutation Detection Kit as CDx for Vectibix Cancer Predisposition Variants Increase Secondary Cancer Mortality Risk in Pediatric Survivors BostonGene, Johns Hopkins University Partner for Multiple Cancer Clinical Research Projects KromaTid, Noble Life Sciences Ink Distribution, OEM Agreement The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.